Last reviewed · How we verify
Placebo for add-back therapy
This drug serves as a placebo for add-back therapy.
This drug serves as a placebo for add-back therapy. Used for Add-back therapy in patients undergoing hormone suppression treatment.
At a glance
| Generic name | Placebo for add-back therapy |
|---|---|
| Sponsor | Bio Genuine (Shanghai) Biotech Co., Ltd. |
| Modality | Small molecule |
| Therapeutic area | Endocrinology |
| Phase | Phase 3 |
Mechanism of action
As a placebo, it does not have a specific mechanism of action. It is used to maintain hormone levels during add-back therapy in patients undergoing hormone suppression treatment.
Approved indications
- Add-back therapy in patients undergoing hormone suppression treatment
Common side effects
Key clinical trials
- Transcranial Magnetic Stimulation on Somtosensory Cortex Enhances Motor Learning in People With Stroke (NA)
- Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type (PHASE2)
- Workplace Exercise Therapy With or Without Manual Therapy in Chronic Spinal Pain (NA)
- Study to Investigate the Potential Pharmacological Effect of Oral Palmitoylethanolamide (PEA) Therapy in the Management of Low Back Pain (Neuropathic Pain) (NA)
- EFFECT OF HAMMAM EXPERIENCE ON GENERAL HEALTH AND PERCEIVED WELL-BEING (NA)
- Efficacy of Spinal Manipulation Therapy or Mindfulness-based Reduction Therapy on Patients With Chronic Low Back Pain (EARLY_PHASE1)
- Effect of Kinesiotaping on Lower Limb Kinematics and Functional Related Outcomes Among Female Athletes With Chronic Lateral Ankle Instability (NA)
- The Effect of Sodium Thiosulfate Eardrops on Hearing Loss in Patients Who Receive Cisplatin Therapy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo for add-back therapy CI brief — competitive landscape report
- Placebo for add-back therapy updates RSS · CI watch RSS
- Bio Genuine (Shanghai) Biotech Co., Ltd. portfolio CI